Skip to content
The GLP-1 Verdict
Menu
Ranked #283 · Grade C

Mojoon review

Premium-priced telehealth provider offering compounded semaglutide.

Visit Mojoon Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $450/mo (starting dose, compounded)
Tirzepatide
Not disclosed
Coverage
Not disclosed
Brand-name
Compounded only

The scorecard

Mojoon scored on our six published factors. See the methodology.

Real-world results69/100
Price honesty64/100
Prescriber access57/100
Formulary choice58/100
Cancellation fairness56/100
Member support74/100

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Premium pricing relative to market

The verdict

Best for: Shoppers who want comprehensive concierge care. Premium-priced telehealth provider offering compounded semaglutide.

Ranked #283 of 499 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. On the board it sits between LunaRx, 63/100 above and Primary Clinic at 63/100 below, with the RxSaludable ruling the next one down.

Weighing it against something else? Every provider we would put in front of Mojoon is ranked on price honesty, prescriber access and cancellation terms. We have also ruled on it directly: CoreAge Rx vs Mojoon goes to CoreAge Rx, 94/100 to 63/100.

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Mojoon's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Mojoon's site. Not medical advice; see our disclosure.

← Back to all rankings